I feel an increasing optimism among shareholders (on this board) based on NP´s last interview. On the one hand, yes, the new details given by NP make it more comprehensive why negotiations have been taking that long. On the other hand, it could just be another smart communicative move by him to soften shareholders´ impatience and lack of content.

The one and only thing that really (!) concerns me - among some minor aspect - is the glaring contradiction between scientific and economic potential of this drug and the value the market grants to CYDY. Is that only due to being listed on OTC? Is this science really real? Is there absolutely no chance of being tricked?

And here we go - investors who are to a certain amount risk-averse would ask themselves exactly those questions. Finally, they would most probably avoid this stock as it sounds too good to be true. That was at least the reactions I experienced when I tried to tell others about this company. A company being able to cure or at least treat HIV, Cancer, NASH etc sitting on OTC and being worth only $200m. *lol* We all know that markets aren´t effective but bargains like that are rarely to be found. So the easiest explanation for CYDY´s massive undervaluation is that it cannot be true.

To make ends meet, I think the most important impact of BLA and a deal would be that the story validates and varifies itself. There will be then a point where there is no doubt about it anymore and I am pretty sure that many investors, who avoid CYDY @30c right now, would buy CYDY if SP was already $1.30. Because then it wouldn´t seem like a bizarre miracle.